In eukaryotes, the biosynthesis of a highly conserved dolichol-linked oligosaccharide (DLO) precursor Glc3Man9GlcNAc2-pyrophosphate-dolichol (PP-Dol) begins on the cytoplasmic face of the endoplasmic reticulum (ER) and ends within the lumen. Two functionally distinguished heteromeric glycosyltransferase (GTase) complexes are responsible for the cytosolic DLO assembly. Alg1, a β-1, 4 mannosyltransferase (MTase) physically interacts with Alg2 and Alg11 proteins to form the multienzyme complex which catalyzes the addition of all five mannose to generate the Man5GlcNAc2-PP-Dol intermediate. Despite the fact that Alg1 plays a central role in the formation of the multi-MTase has been confirmed, the topological information of Alg1 including the molecular mechanism of membrane association are still poorly understood. Using a combination of bioinformatics and biological approaches, we have undertaken a structural and functional study on Alg1 protein, in which the enzymatic activities of Alg1 and its variants were monitored by a complementation assay using the GALpr-ALG1 yeast strain, and further confirmed by a liquid chromatography-mass spectrometry-based in vitro quantitative assay. Computational and experimental evidence confirmed Alg1 shares structure similarity with Alg13/14 complex, which has been defined as a membrane-associated GT-B GTase. Particularly, we provide clear evidence that the N-terminal transmembrane domain including the following positively charged amino acids and an N-terminal amphiphilic-like α helix domain exposed on the protein surface strictly coordinate the Alg1 orientation on the ER membrane. This work provides detailed membrane topology of Alg1 and further reveals its biological importance at the spatial aspect in coordination of cytosolic DLO biosynthesis.
Introduction
In the initial step of N-glycosylation, the dolichol-linked oligosaccharide (DLO) precursor synthetic pathway occurs on the endoplasmic reticulum (ER) membrane, where 14 monosaccharide residues are sequentially transferred onto a dolichyl pyrophosphate (PP-Dol) carrier molecule to form the core oligosaccharide precursor Glc3Man9GlcNAc2-PP-Dol (Burda and Aebi 1999; Kelleher and Gilmore 2006; Weerapana and Imperiali 2006; Schwarz and Aebi 2011; Samuelson and Robbins 2015) . A series of ER membraneassociated glycosyltransferases (GTases), known as Alg (Asparaginelinked glycosylation) proteins, catalyze the synthesis of DLO (Larkin and Imperiali 2011; Schmaltz et al. 2011; Aebi 2013) . Noteworthy, a phosphoglycosyl transferase that catalyzes the first reaction of DLO synthesis, by adding GlcNAc-1-P from cytoplasmic UDPGlcNAc to dolichyl phosphate (P-Dol) is also classified into Alg proteins and named as Alg7 (Lehrman 1991) . The first seven reactions of DLO synthesis occur on the cytoplasmic face of the ER membrane, producing the Man5GlcNAc2-PP-Dol intermediate that will be translocated to the ER lumen for further elongation (Helenius and Aebi 2004) . Thus far, six Alg proteins are known to be responsible for the cytosolic biosynthesis of DLO. These enzymes are organized into two functionally distinct multi-GTase complexes. The first complex consists of Alg7 and a novel heterodimeric UDPGlcNAc transferase Alg13/14, which catalyzes the conversion of dolichol-P to GlcNAc2-PP-Dol (Noffz et al. 2009; Lu et al. 2012) . Next, five reactions in a row are catalyzed by a multimannosyltransferase (MTase) complex that includes Alg1, Alg2 and Alg11 proteins (Gao et al. 2004; O'Reilly et al. 2006; Takahashi and Gao 2012; Aebi 2013) .
Alg13/14 transferase catalyzes the second reaction of DLO synthesis, which produces GlcNAc2-PP-Dol by transferring a β-1,4-linked GlcNAc from UDP-GlcNAc to GlcNAc-PP-Dol (Bickel et al. 2005; Chantret et al. 2005; Gao et al. 2005) . Alg13/14 transferase shares structural similarity with the bacterial MurG protein, a typical membrane-associated GT-B GTase involved in peptidoglycan biosynthesis of Escherichia coli (Mengin-Lecreulx et al. 1991; Ha et al. 2000 Ha et al. , 2001 . Alg13 subunit possesses the catalytic domain similar to the C-terminal domain of MurG, while Alg14 was predicted to contain a lipid acceptor and membrane-associating domain, found in the N-terminal domain of MurG (Averbeck et al. 2008; Gao et al. 2008; Wang et al. 2008 ). In addition, Alg14 also possesses a transmembrane domain (TMD) at its N-terminus contributing to the membrane association of Alg13/14 transferase. In Alg7 and Alg13/14 complexes, Alg14 not only recruits the cytosolic Alg13 subunit to the ER membrane but also interacts with Alg7 through its N-terminal TMD, indicating its central role in the formation of the first GTase complex (Lu et al. 2012; Albesa-Jove et al. 2014) . Noticeably, such important biological functions of Alg14 can be ascribed to its unique molecular mechanism of membrane association with the ER.
The product of Alg13/14 transferase, the GlcNAc2-PP-Dol intermediate, is relayed to the multi-MTase complex and becomes the substrate for Alg1. Alg1 is a β-1,4 MTase that transfers the first mannose from GDP-mannose onto GlcNAc2-PP-Dol, generating ManGlcNAc2-PP-Dol (Albright and Robbins 1990) . In yeast cells, loss of the ALG1 gene leads to cell death, demonstrating that Alg1 protein is essential for cell viability, while in humans, mutation of the ALG1 gene leads to an autosomal recessive disease, known as ALG1-CDG, congenital disorders of glycosylation (Rohlfing et al. 2014; Ng et al. 2016 ). Co-immunoprecipitation experiments indicated that yeast Alg1 not only strongly interacts with itself but also with Alg2 and Alg11 proteins (Gao et al. 2004) . Furthermore, human Alg1, Alg2 and Alg11 proteins were also confirmed to interact with each other at a ratio of 2:1:1 using a yeast split-ubiquitin system . These results demonstrated physical associations between Alg1 and functionally related Alg2 and Alg11 enzymes, suggesting the formation of an Alg1/Alg2/ Alg11 multi-MTase complex.
Considering the fact that both Alg1 and Alg13/14 are the central unit of membrane-associated multi-GTase complexes involved in cytosolic DLO synthesis, it is reasonable to speculate that structural similarities between Alg1 and the Alg13/14 may indicate the biological importance of Alg1 or the Alg13/14 in the DLO synthetic pathway, in addition to their enzymatic activities. To verify our hypothesis, we conducted a structural and functional study of the yeast Alg1 protein, specifically focusing on the molecular mechanism of its ER membrane association and then compared our findings with the Alg13/14. Here, we provide clear evidence that the N-terminal TMD, including the subsequent positively charged amino acids, and an N-terminal amphiphilic-like α-helix domain exposed on the protein surface strictly coordinate the Alg1 orientation on the ER membrane. Notably, in combination with an in vitro quantitative assay (Li et al. 2017) , we revealed the implicit topological importance of Alg1, and likely the Alg13/14 as well, in the DLO synthetic pathway.
Results
Alg1 protein shares structural similarities with the heterodimeric Alg13/Alg14 GTase To gain structural information, the amino acid sequence (449 amino acids) of Alg1 from S. cerevisiae (scAlg1) was subjected to a topology prediction via the Transmembrane Hidden Markov Model (TMHMM) program (http://www.cbs.dtu.dk/services/TMHMM/). Taking advantage of the recent advances in the bioinformatics field, our algorithms did confirm up to four possible membrane-spanning helices that had been indicated in yeast Alg1 in a previous study (Gao et al. 2004 ), but only the first hydrophobic α-helix domain from L10 to Y32 had a high score of posterior probability, supporting the existence of only one TMD at the N-terminus of Alg1 ( Figure 1A ). Similar N-terminal TMD has been experimentally confirmed in Alg14 protein, one of the subunits in Alg13/14 transferase. Furthermore, scAlg1 sequence from R40 to H449 (without an N-terminal domain including the TMD) was subjected to a stereostructure analysis using phyre Ver.2 (http://www.sbg.bio.ic.ac.uk/ phyre2). Our analysis revealed two distinct Rossmann-fold domains adopting the typical architecture of GT-B GTase (Bourne and Henrissat 2001) . As shown in Figure 1B , the predicted 3D structure of Alg1 shares markedly high similarity with the E. coli UDP-GlcNAc transferase MurG (PDB; 1F0K), a paradigm of the GT-B superfamily. The structure of Alg1 was then thoroughly compared to the Alg13/14 transferase. Like MurG, it was confirmed that the C-terminal domain of Alg1 is predicted to contain a conserved catalytic domain of a GTase similar to Alg13, while the N-terminal domain of Alg1 contains a hydrophobic membrane-associating surface that can also be found in the Alg14 protein ( Figure 1B ). In particular, our structural analysis revealed that the third N-terminal α-helix domain (Nα3) of Alg1 is exposed on the protein surface ( Figure 1B left panel, circled in black). Furthermore, the amino acid sequence of the Alg1 Nα3 domain from I107 to E126 is also predicted as a second hydrophobic region by TMHMM analysis, suggesting its involvement in membrane association ( Figure 1A ). Similar α-helix domains can also be confirmed on the surface of the Alg13/14 ( Figure 1B , right panel, circled in black as α3), which has been demonstrated to be the primary structure of the monotopic membrane association interface of Alg14 (Lu et al. 2012) . Taken together, our computational studies suggest high structural and topological similarities between Alg1 and the Alg13/14. Both GTases have an N-terminal TMD connected with two distinct Rossmann-fold domains, revealing the typical structure of membrane-associated GT-B GTase.
The predicted TMD orientates the N-terminus of Alg1 into the ER lumen Our results from the new TMHMM program only predicted the first α-helix domain as a TMD of Alg1 ( Figure 1A) . However, the amino acid alignment of the predicted TMD among the various Alg1 proteins revealed a highly conserved proline residue at the center of TMD (Figure 2A , red arrow head), which is known as a helix breaker (von Heijne 1991; Visiers et al. 2000) . To validate whether the predicted TMD of Alg1 plays a role in associating with the ER membrane, we first constructed an Alg1N32-GFP plasmid that expresses the first 32 amino acids of yeast Alg1 fused with the N-terminus of green fluorescent protein (GFP). The fluorescence microscopy analysis indicated that Alg1N32-GFP co-localizes with the ER marker KmRFP ( Figure 2B ). Protein extracts were also prepared from Alg1N32-GFP-expressing cells and fractionated by centrifugation, followed by western blotting with anti-GFP antibody. The result showed that Alg1N32-GFP was primarily present in the ER membrane-enriched fraction, while GFP-only largely existed in cytosol ( Figure 2C ).
To further validate whether the conserved proline residue affects the membrane association property of TMD, we then inserted a 53-amino acid-length S2A cassette fused with FLAG into either N-or C-terminal of Alg1 and confirmed the orientation of Alg1 N-terminus in ER membrane. The S2A fragment containing three NX(S/T) glycosylation sites was wildly used to study the topology of membrane proteins (Gilstring and Ljungdahl 2000; Han et al. 2004; Kageyama-Yahara and Riezman 2006; Sagane et al. 2011) . Each construct is capable to maintain the XGY29 cells growth on glucose-containing medium (data not shown). The state of protein glycosylation in both two S2A-fused Alg1p was identified ( Figure 2D ). As shown in Figure 2D (left panel), the Nterminal S2A-inserted Alg1p (FLAG-S2A-Alg1) was N-glycosylated by confirming the shift of protein band after PNGase treatment, whereas the C-terminal inserted form (Alg1-S2A-FLAG) was not, indicating that the N-and C-termini of Alg1 were located to luminal and cytosolic side of the ER, respectively. In addition, we mutated the conserved proline residue in FLAG-S2A-Alg1 to leucine, which generated FLAG-S2A-Alg1-P20L, and also checked the orientation of its N-terminus. As shown in Figure 2D (right panel), there is no difference in N-glycosylation pattern after the replacement of proline residue. In sum, our results demonstrated that the predicted N-terminal TMD is sufficient to target the Alg1 to the ER membrane with its N-terminus facing to the lumen, and also the conserved proline residue has no effect on its membranespanning property.
N-terminal deletion of Alg1 causes growth defects at high temperature
To further understand the significance of the Alg1 N-terminus, we manipulated the N-terminal region of Alg1 by deleting the first 32 (alg1NΔ32), 40 (alg1NΔ40) or 50 (alg1NΔ50) amino acids. Each (C) Subcellular fractionation of Alg1N32-GFP fusion protein and soluble GFP. Detergent extracts from strains expressing Alg1N32-GFP or GFP-only were separated into P13, P100 and S100 fractions by centrifugation and then subjected to SDS-PAGE and western blotting with an anti-GFP antibody. (D) Western blotting analysis of FLAG-tagged and S2A-fused Alg1p or Alg1-P20L mutant. ER-enriched membrane fractions of the transformed cells described above were prepared. PNGase F-untreated (−) and -treated (+) ER-enriched membrane fractions were separated by SDS-PAGE and analyzed by immunoblotting using anti-FLAG monoclonal antibody. SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis; TMD, transmembrane-spanning domain; GFP, green fluorescent protein; ER, endoplasmic reticulum.
mutant allele was N-terminal tagged with a 3FLAG epitope and constructed into a CEN-containing plasmid under the control of the yeast ALG1 promoter ( Table I) . As shown in Figure 3A , Alg1NΔ32 protein lacks the predicted N-terminal TMD, and further deletion of additional eight amino acids, including four positively charged residues (emphasized in red), resulted in Alg1NΔ40. Moreover, in Alg1NΔ50, the first β-sheet of Alg1 was completely eliminated. These Alg1 proteins were first expressed in the XGY29 strain, in which chromosomal ALG1 is under the control of the glucoserepressible GAL1/10 promoter. Enzyme activities of these Alg1 mutants were judged by testing their ability to support cell growth after repression of ALG1 expression on glucose-containing media at the normal (30°C) or a higher (37°C) temperature ( Figure 3B and C). The protein stability of these mutants was examined by western blotting using anti-FLAG antibody ( Figure 3D ).
Among these N-terminal deletions, alg1NΔ50 failed to rescue cell growth at the 30°C ( Figure 3B ). Western blotting result revealed a seldom protein expression in ER membrane fraction ( Figure 3D ), suggesting a protein destabilization caused by the Nterminal 50-amino-acid truncation. In contrast, cells expressing alg1NΔ32 showed normal growth, similar to those expressing fulllength Alg1, at normal temperature (30°C) and also relatively similar protein expression level ( Figure 3B , C and D). However, when the temperature was raised to 37°C, alg1NΔ32-expressing cells showed an obvious growth defect ( Figure 3C ). In agreement with our previous studies on TMD (Figure 2 ), this result further demonstrates the importance of N-terminal 32 amino acids including the TMD in Alg1 biological function. To analyze whether these positively charged amino acids locating at downstream of the TMD participate in the association with the ER membrane, the effect of alg1NΔ40 on the cell growth phenotype and the protein expression of alg1NΔ40 were also tested. The alg1NΔ40-expressing cells exhibited a similar growth state as wild-type Alg1-expressing cells at 30°C ( Figure 3C ), and proteins were expressed at the compatible level ( Figure 3D ). However, the temperature sensitivity of them was more severe than that of the alg1NΔ32-expressing cells at 37°C ( Figure 3C ), suggesting that these positively charged residues also contribute to the activity of Alg1.
Protein distribution and membrane extraction data suggest a second membrane association site in Alg1
To explore whether the N-terminal deletion of Alg1 has effects on its intracellular localization, protein fractionation of Alg1 and Alg1NΔ40 was performed using centrifuge sedimentation. Cell lysates extracted from XGY31 cells expressing 3FLAG-Alg1 and XGY33 cells expressing 3FLAG-Alg1NΔ40 were centrifuged at 13,000 × g to separate the ER membrane fraction (M). The resulting supernatant (S) fractions contained lighter membrane components (the Golgi and small transport vesicles) and soluble cytosolic proteins. Equivalent amounts of protein from each fraction were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotted with anti-FLAG antibody to detect proteins ( Figure 4A ). We observed that both Alg1 and Alg1NΔ40 were primarily located in the ER membrane fraction (M in Figure 4A ) but not in the supernatant fraction (S in Figure 4A ), indicating that the deletion of the Alg1 N-terminus does not alter its ER membrane distribution. This result led us to hypothesize that there might be a second, undefined membrane-associated domain in Alg1.
To determine the membrane association mode of this second domain, we treated ER membrane fractions of Alg1 and Alg1NΔ40 cells with sodium carbonate (Na 2 CO 3 ) (which releases peripheral but not integral membrane proteins) and 0.2% SDS detergent (which releases both peripheral and integral membrane proteins). Under these conditions, Alg1NΔ40 was released from the ER membrane by 0.2% SDS but not by Na 2 CO 3 (pH 11) extraction ( Figure 4B ), indicating that there is no significant difference between intact Alg1 and Alg1NΔ40. This result demonstrated that Alg1NΔ40 associates with the ER membrane in a nonperipheral manner, as does Alg1. Bacterial expression vector containing His-tag pXX1 3FLAG-ALG1 expressed from ALG1 promoter in pRS306 pXX2 3FLAG-alg1NΔ32 expressed from ALG1 promoter in pRS306 pXX3 3FLAG-alg1NΔ40 expressed from ALG1 promoter in pRS306 pXX4 3FLAG-alg1NΔ50 expressed from ALG1 promoter in pRS306 pXX5
Alg1N32-GFP expressed in YEp352-GAPII pXX6 3FLAG-alg1-V106A/M109A/V110A/V113A/V117A/I120A (3FLAG-alg1-mut6A) expressed from ALG1 promoter in pRS306 pXX7 3FLAG-alg1NΔ32-V106A/M109A/V110A/V113A/V117A/I120A (3FLAG-alg1NΔ32-mut6A) expressed from ALG1 promoter in pRS306 pXX8
alg1NΔ32 expressed with N-terminal His-tag in pET28a pXX11 alg1Δ40-mut6A expressed with N-terminal His-tag in pET28a pXX12 3FLAG-alg1NΔ32-KtoA-mut6A expressed from ALG1 promoter in pRS306 pXX13
A conserved α-helix domain contributes to the membrane association of Alg1 protein
To gain information about the additional membrane association site, structural information of Alg1 was reviewed. Our attention focused on its third α-helix domain ( Figure 1B , indicated as Nα3). Analysis of the amino acid sequence further revealed that almost all the hydrophobic residues of this domain are arranged to one side of the helix, and this led us to consider the Nα3 structure an amphiphilic α-helix ( Figure 5A ).
To further confirm the function of the Alg1 Nα3 domain in ER membrane association, a mutagenic analysis of its hydrophobic face was performed. Total six hydrophobic amino acids (V106, M109, V110, V113, V117 and I120) ( Figure 5B) of yeast Alg1 or Alg1NΔ40 were replaced with A (alanine) residues to form Alg1-mut6A or Alg1NΔ40-mut6A. Plasmids expressing 3FLAG-tagged alg1-mut6A or alg1NΔ40-mut6A were introduced into the P GAL1 -ALG1 strain (XGY29) to determine if they would rescue the growth defect when grown on glucose medium. As shown in Figure 5C , the expression of Alg1-mut6A completely complements the loss of Alg1, suggesting that substitution of the six hydrophobic residues did not alter the biological activity of Alg1 at 30°C. However, the expression of Alg1NΔ40-mut6A failed to rescue the cell viability of the XGY29 strain, indicating that the combination of N-terminal TMD deletion and Nα3 domain mutagenesis of Alg1 protein caused growth defect in yeast cells. To further test whether the hydrophobic property of the Alg1 Nα3 domain is biologically important, we constructed a 3FLAG-tagged Alg1NΔ40-mut6 hydrophobic protein, in which V106 was replaced with I, M109 was replaced with L, V110 was replaced with I, V113 was replaced with I, V117 was replaced with I, and I120 was replaced with L (hydrophobic mut6 substitution) and introduced it into the P GAL1 -ALG1 strain (XGY29). As expected, this mutant Alg1 protein with hydrophobic mut6 substitution possesses the ability to recover the cell growth of the XGY29 strain ( Figure 5C ). In agreement with the complementation assay, western blotting of the membrane fractions of each Alg1 mutant showed that Alg1-mut6A exhibited the same protein level as wild-type Alg1 ( Figure 5D ). However, Alg1NΔ40-mut6A was barely detected in either the membrane fraction ( Figure 5D ) or the cytosolic fraction (data not shown), indicating that this mutant protein had been degraded. Meanwhile, the protein level of Alg1NΔ40-mut6 hydrophobic was higher than that of Alg1NΔ40-mut6A, indicating that it resisted degradation by associating with the ER membrane and retained biological function, which was enough to rescue the loss of Alg1. Crude protein extracts were prepared from yeast strains (XGY31 or XGY33) expressing 3FLAG-ALG1 or 3FLAG-alg1NΔ40 and separated into membrane fractions and supernatant fractions as described in Materials and methods. Protein (20 μg) from each fraction was separated by 10% SDS-PAGE and analyzed by immunoblotting using antibodies against FLAGtagged proteins and Dpm1 (an ER marker). (B) Membrane extraction of Alg1 and Alg1NΔ40 proteins. The ER membrane fractions were treated with 0.2% SDS or 0.1 M Na 2 CO 3 (pH 11) and further centrifuged at 100,000 × g to separate membrane and soluble proteins as described. Equivalent amounts of proteins from the pellet (P) and supernatant (S) were examined using western blotting. SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis; ER, endoplasmic reticulum.
Interestingly, Alg1NΔ32-mut6A appeared to function similar to intact Alg1 at 30°C and a similar expression level as wild-type Alg1 ( Figure 5C and D). To further confirm this finding, K35A, K38A, K39A and R40A substitutions were introduced into alg1NΔ32-mut6A and the resulting alg1NΔ32-KtoA-mut6A mutant gene was then transformed into XGY29 to test its effect on cell growth and the protein expression level. It was found that Alg1NΔ32-KtoAmut6A containing K35A, K38A, K39A, R40A mutagenesis resulted in slower growth and decreased protein amount in membrane fraction than that of Alg1NΔ32-mut6A ( Figure 5C and D) , further demonstrating that the positively charged amino acids (K35, K38, K39 and R40; Figure 3A) downstream of the N-terminal transmembrane region are important for ER membrane attachment. Collectively, our results demonstrated that the hydrophobic face of the Alg1 helix Nα3 is not directly required for cell viability and that the absence of both the N-terminal region and the hydrophobic face causes degradation of the protein.
Alg1NΔ40-mut6A mutant protein shows activity in vitro
From the results shown in Figure 5 , we proposed that the Alg1NΔ40-mut6A protein undergoes degradation due to its loss of ability to interact with the ER membrane rather than its loss of normal Alg1 activity. To determine whether the Alg1NΔ40-mut6A has enzymatic activity, His-tagged Alg1NΔ40-mut6A was stably expressed in E. coli cells and purified using a HisTrap HP affinity column as described in Materials and methods. The Alg1NΔ32 was also prepared and used as a positive control. The β-1,4 MTase activity of the purified Alg1 proteins were then tested using a new in vitro assay, in which GlcNAc2-pyrophosphate-phytanyl (GlcNAc2-PP-Phy) was used as the acceptor substrate instead of the natural substrate, GlcNAc2-PP-Dol. After incubating mutant proteins with the reaction mixture for 30 min under the conditions described in Materials and methods, the product oligosaccharides were directly detected and quantitatively analyzed by normal-phase liquid chromatography (LC) coupled with electrospray ionization mass spectrometry (ESI-MS). As shown in Figure 6A , both substrates and products revealed two groups of peaks in the LC chromatogram, which were predicted to correspond to GlcNAc2 and ManGlcNAc2. Further analysis using ESI-MS demonstrated that the first two peaks eluted at 5.85 and 6.23 min originate from the substrate GlcNAc2-PP-Phy, possessing a mass peak (m/z) of 447 ( Figure 6A, [GlcNAc2+Na] + ), and the later two peaks eluted at 8.91 and 9.21 min originate from the product ManGlcNAc2-PPPhy, possessing a mass peak (m/z) of 609 ( Figure 6A ,
. To determine each of the Alg1 mutant activities, the relative percentages of substrate (5.85 and 6.23 min) and product (8.91 and 9.21 min) oligosaccharides remaining after The illustration shown here was generated on the basis of the Alg1 structure predicted by phyre Ver.2. Helix Nα3 is shown as a ribbon. The hydrophobic residues (V106, M109, V110, V113, V117 and V120) marked with red were mutated to A (alanine). (C) Complement assay of Alg1 variants. Plasmids containing 3FLAG-ALG1, 3FLAG-alg1NΔ40, 3FLAG-alg1-mut6A, 3FLAG-alg1NΔ40-mut6A, 3FLAG-alg1NΔ40-mut6 hydrophobic , 3FLAG-alg1NΔ32-mut6A, 3FLAG-alg1NΔ32-KtoA and 3FLAG-alg1NΔ32-KtoA-mut6A were transformed into XGY29 cells. These Alg1 variant-containing cells were spotted on YPA plates supplemented with glucose at 30°C. (D) Western blotting of Alg1 variant proteins. ER-enriched membrane fractions of the transformed cells described above were prepared. Protein (20 μg) from each fraction was separated by SDS-PAGE and analyzed by immunoblotting using antibodies against FLAG-tagged proteins and Dpm1. SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis; ER, endoplasmic reticulum.
completion of the reactions were calculated. As shown in Table II , after a 30-min reaction, AlgNΔ32 protein converted 76.70% of the GlcNAc2 substrate to the ManGlcNAc2 product, while the Alg1NΔ40-mut6A converted 67.96% of GlcNAc2 to ManGlcNAc2, revealing comparable MTase activity between two Alg1 mutant proteins. This result confirmed that helix Nα3 of Alg1 acts only as a second ER membrane-associated region and further suggested that degradation of the Alg1NΔ40-mut6A was due to its inability to attach to the ER membrane.
Alg1 protein transfers a second β-linkage mannose to the GlcNAc2-PP-Phy substrate Using our new in vitro assay, we incidentally found that extending the incubation time led to the addition of a second mannose to GlcNAc2-PP-Phy. To confirm this unexpected enzymatic activity, Alg1NΔ32 protein expressed in E. coli was incubated with the enzyme assay reaction mixture as described in the Materials and methods. The product oligosaccharides were sampled at different incubation times and then subjected to the LC-MS analysis. As confirmed in our former experiment (Figure 6 ), the ultraperformance liquid chromatography (UPLC) results revealed that ManGlcNAc2 eluted at approximately 8.7 and 9.0 min from all the reaction mixtures with the indicated incubation times ( Figure 7A, 1, 4 and  24 h ). An additional group of two peaks eluted at approximately 10.7 and 11.0 min was also detected ( Figure 7A ). These two peaks scarcely appeared in the sample prepared after incubation for 1 h but gradually increased with extension of the incubation time. ESI-MS analysis revealed a mass peak at 771 m/z, corresponding to a [ManGlcNAc2 + Hexose] structure ( Figure 7B ). Notably, unlike in Figure 6A , no peaks corresponding to GlcNAc2 were observed to elute at approximately 6.0 min in the chromatogram shown in Oligosaccharides released from the various LLOs in the mixture were analyzed by ultraperformance liquid chromatography-mass spectrometry (UPLC-MS) as described in Materials and methods. a The relative percentage of oligosaccharide was calculated by dividing the area of each corresponding oligosaccharide peak to the total area of all peaks. Chromatograms of oligosaccharides in each of these reactions are shown in Figure 6 . Figure 7A , indicating depletion of the substrate GlcNAc2-PP-Phy after extension of the incubation time. To determine the linkage information of the additional hexose, the product oligosaccharides were treated with α-mannosidase or β-mannosidase. The treatment with α-mannosidase had no effects on ManGlcNAc2 and [ManGlcNAc2+Hexose] oligosaccharides, while the β-mannosidase treatment shifted the elution time of peaks corresponding to ManGlcNAc2 and [ManGlcNAc2+Hexose] to 5.77 and 6.19 min ( Figure 7C ). ESI-MS analysis confirmed that these two peaks corresponded to GlcNAc2 (data not shown). Therefore, the in vitro enzymatic analysis demonstrated that the additional hexose attached to ManGlcNAc2 was also a β-1,4-linked mannose.
Discussion
Alg1 protein forms a heteromeric MTase complex with Alg2 and Alg11 that coordinates the cytosolic mannosylation of DLO synthesis on the ER membrane. Despite the experimental evidence that demonstrated Alg1 is a membrane-associated protein, little is known about how it interacts with ER surface. In this study, we successfully carried out an investigation on structure-function relationship of yeast Alg1, especially focusing on its membrane interaction.
Membrane-associated GT-B GTases comprise a large family of enzymes that catalyze the transfer of a sugar moiety from nucleotidesugar donors to a wide range of membrane-associated acceptor substrates (Lu et al. 2012; Albesa-Jove et al. 2014) . The cytosolic GTases of the Alg family are qualified for this classification. However, among them, only the Alg13/14 transferase has been experimentally confirmed (Lu et al. 2012) . Our bioinformatics analysis on yeast Alg1 observed a typical structure of membrane-associated GT-B GTase similar with the Alg13/14 (Figure 1 ). To gain direct biological evidence and verify our observation, we designed a series of experiments for studying the ER membrane association of Alg1 by following a strategy similar to the one we previously used for structural analysis of yeast Alg13/14 (Lu et al. 2012 ). As we expected, our study not only confirmed the similar mechanism of membrane association between these two adjacent Alg GTases but also made several progresses through further analysis.
One of the progresses is that a series of N-terminal positively charged amino acids (K35, K38, K39 and R40) contribute to the membrane association (Figure 5D , compare the western-blot results between Alg1NΔ32-mut6A and Alg1NΔ40-mut6A or Alg1NΔ32-KtoA-mut6A), which affected growth phenotypes of yeast cells ( Figure 3C , compare the growth phenotype of alg1NΔ32 and alg1NΔ40; also Figure 5C , alg1NΔ32-mut6A and alg1NΔ40-mut6A). These amino acids are subsequent to the N-terminal TMD (from 10 to 32 amino acids). Based on the orientation result of TMD (Figure 2) , they locate between TMD and the Rossmann-fold domains on the cytosolic surface of ER membrane (Figure 8 , K/R cluster). This observation was also strongly supported by our biostatistics analysis, which revealed the existence of positively charged residues at a similar position not only in all Alg1 proteins but also in various Alg14 proteins (data not shown). A likely explanation for this phenotype is that these positive residues can associate with negatively charged phosphatidylinositol phosphate lipids on the membrane (Do Heo et al. 2006) .
Another progress we made here is the verification of MTase activity on Alg1NΔ40-mut6A ( Figure 6A ). This protein had been mutagenized with the combined loss of the N-terminal region (comprising the TMD and positively charged amino acid cluster) and the hydrophobic face of helix Nα3. Our analysis on this mutant revealed a severe protein degradation and the failure to complement the loss of Alg1 ( Figure 5D ). Our in vitro quantitative assay (Li et al. 2017) directly demonstrated a compatible MTase activity between the E. coli-expressed Alg1NΔ40-mut6A and the positive control, Alg1NΔ32 protein (Figure 6 ), suggesting that the degradation of Alg1NΔ40-mut6A is caused by its inability to interact with the ER membrane. This result further confirmed that helix Nα3 is a second membrane-associated site of Alg1. In the previous study on Alg14 helix α3, an Alg14Δ47-mut6A mutant also showed the similar phenomenon, but the explanation for its phenotypes is remained incomplete because it locked the direct evidence to demonstrate its GTase activity (Lu et al. 2012) . Our explanation on Alg1 helix Nα3 can be applied to support the Alg14 helix α3 case.
Collectively, based on informatics predictions, molecular biological analyses and direct assay of enzymatic activities, we confirmed that Alg1 ensures its ER membrane association through a combination of the N-terminal TMD, the subsequent positively charged amino acids and the amphiphilic-like helix Nα3 located in the N-terminal Rossmann-fold domain (Figure 8 ). Similar structures can be confirmed in Alg14, the N-terminal subunit of the Alg13/14 (Lu et al. 2012) , emphasizing that Alg1 and Alg13/14 transferases share analogous ER membrane association mechanisms. Notably, the Alg13/14 and Alg1 not only catalyze two adjacent reactions of glycosylation but also work as the central unit of multi-GTase complexes (Gao et al. 2004; Lu et al. 2012) . Obviously, such topological similarity can be considered to benefit the efficiency of sequential reactions in early steps of the DLO pathway. Meanwhile, from a biological point of view, we considered that such an unusual membranebinding mechanism of Alg1 or Alg13/14 may be required for its specialized catalytic mechanism and working environment. The Alg1 protein works at the surface of the ER membrane, a membrane-water interface, where it catalyzes the transfer of a β-1,4-linked mannose with inversion of the anomeric configuration (Albesa-Jove et al. 2014) . Therefore, Alg1 must have the remarkable ability to recognize both the hydrophilic water-soluble nucleotide-sugar donor (GDPmannose) and the hydrophobic lipid acceptor (GlcNAc2-PP-Dol). We can speculate that the accurate stereochemical outcome of such a reaction mediated by Alg1 or the Alg13/14 requires stable membrane association and precise orientation.
Corresponding to the above speculation, we coincidently found that the soluble Alg1NΔ32 was capable of transferring an additional β-1,4-linked mannose onto a GlcNAc2-PP-Phy substrate under extended reaction times ( Figure 7 ). As we proposed in Figure 8 , the additional modification of a second β-1,4-linked mannose can only be confirmed in the in vitro solution system, in which only the purified Alg1NΔ32 was used for the reaction, without the presence of any other proteins or membrane fractions. However, under in vivo Fig. 8 . Schematic diagram of the reaction process of Alg1 protein in β-1,4-mannosylation. Alg1 recognizes both the hydrophilic water-soluble nucleotide-sugar donor and the hydrophobic lipid acceptor. In the in vivo situation, Alg1 tightly interacts with the ER membrane through its N-terminal TMD, which spans the lipid bilayer, and a membrane-binding interface (Nα3), which associates with the cytosolic monolayer of the ER membrane. In addition, four positively charged amino acids (emphasized in blue) also contribute in this interaction. This stable membrane association and precise orientation of Alg1 maintains the stringent substrate specificities required during DLO biosynthesis, consequently preventing extra modification of the sugar chain. However, in our in vitro assay, Alg1NΔ32, a soluble Alg1 protein with almost intact enzyme activity catalyzes not only the transfer of β-1,4-linked mannose from GDP-mannose to GlcNAc2-PPPhy but also the transfer of additional β-linked mannose from GDP-mannose to ManGlcNAc2-PP-Phy.
circumstances, the strict membrane association mechanism of Alg1 will strongly prohibit this extra modification to maintain the stringent substrate specificities of DLO synthesis. Thus, our results reveal the topological importance of Alg1 protein in regulation and coordination of reactions during cytosolic DLO synthesis. Studies on the 3D structure of Alg1 will provide a clear molecular mechanism describing how Alg1 precisely controls the modification of the first mannose and further coordinates the rest of cytosolic mannosylation in the DLO synthetic pathway.
Materials and methods

Plasmids, strains and culture conditions
All plasmids and yeast strains used in this study are listed in Tables I  and III , respectively. Plasmids were constructed by standard molecular biological methods, and site-directed mutagenesis of different alg1 mutant genes was conducted by fusion-PCR and verified by DNA sequencing. The primer sequences used in this study are available upon request. All Alg1 and its mutant proteins were expressed under ALG1 own promoter with 3FLAG at the N-terminus. Plasmid pXX5 expresses an Alg1N32-GFP fusion gene encoding the first 32 amino acids of Alg1 in frame with GFP lacking its initiating ATG under the control of TDH3 promoter. Plasmid pSA21 expresses KAR2-mRFP-HDEL as an ER marker (Gao et al. 2005) . For expression in E. coli, alg1 mutants were constructed on pET28a plasmid (Li et al. 2017) .
Saccharomyces cerevisiae W303a (MATa his3-11 leu2-3, 112 ura3-1 trp1-1 ade2-1 can1-100) strain was used as the parental strain in this study. In XGY29 strain, the chromosomal ALG1 promoter was replaced with the glucose-repressible GAL1/10 promoter to test the activity of Alg1 variant proteins. Each plasmid containing a 3FLAG-tagged alg1 variant allele was integrated at the ura3 locus of XGY29 (Gao et al. 2004 ). Yeast cells were cultured in rich medium YPA (1% yeast extract, 2% peptone, 50 mg/L adenine) supplemented with 2% glucose (YPAD) or 2% galactose (YPAG) or in synthetic minimal medium containing 0.67% yeast nitrogen base (Sigma, MO), 2% glucose, supplemented with appropriate amino acids.
Fluorescence microscopy of Alg1N32-GFP fusion protein
To visualize the localization of Alg1N32-GFP and KmRFP fusion proteins, wild-type (W303a) cells were transformed with pXX5 and pSA21 and grown to an OD 600 of 1-3 in YPAD medium. After washing the cells by the PBS with 2% glucose, GFP fluorescence was imaged by Nikon Eclipse Ti-E inverted microscope equipped with DS-Ri1 camera and NIS-Element AR software (Nikon, Tokyo, Japan).
Preparation of protein extracts, membrane extraction and western blotting
Protein extraction from yeast cells were conducted as follows. The cells were lysed as previously described (Gao et al. 2005; Lu et al. 2012) , and the cell lysates were centrifuged at 1,000 × g for 10 min to remove unlysed cells and cell wall debris. The supernatant was collected as a crude extract and then centrifuged again at 13,000 × g for 15 min, giving the pellet containing ER proteins (M/P13) and the supernatant (S/S13) fraction. The S13 fraction was centrifuged at 100,000 × g for 60 min to yield the P100 pellet and S100 supernatant. The P13 and P100 fractions were resuspended in a suitable amount of lysis buffer (0.2 M sorbitol, 1 mM EDTA, 50 mM TrisHCl, pH 7.5) containing protease inhibitors. For membrane extraction, the ER membrane fraction (M) was resuspended in 100 μL of TE (pH 7.2) containing 0.2% SDS or 0.1 M Na 2 CO 3 (pH 11), then incubated on ice for 30 min, further centrifuged at 100,000 × g for 15 min at 4˚C. The supernatants were collected and the pellets resuspended with 100 μL of lysis buffer.
For western blotting, appropriate amount of proteins were subjected to 10% or 12% SDS-PAGE and transferred to PVDF membranes (Bio-rad, Shanghai, China). Protein concentrations were determined by Nano-Drop (Thermo scientific, MA). Mouse anti-FLAG and anti-GFP (Transgen, Beijing, China) or anti-Dpm1 (Abcam, Shanghai, China) antibodies were used as primary antibodies at 1:5,000 dilutions. Goat anti-mouse IgG-HRP (Transgen, Beijing, China) were used as secondary antibodies at 1:7,000 dilution. Signals were visualized by Clarity Western ECL Substrate (Biorad, Shanghai, China) and images were obtained by using Image Quant LAS4000 (GE Healthcare Bio-Science, Uppsala, Sweden).
Expression and purification of mutant alg1 proteins
Mutant Alg1 proteins (Alg1NΔ32 and Alg1NΔ40-mut6A) were expressed and purified as described previously (Li et al. 2017) . Briefly, E. coli BL21-CodonPlus (DE3) cells harboring pET28a-His6-alg1NΔ32 or pET28a-His6-alg1NΔ40-mut6A were cultured in TB medium at 37°C until OD 600 reached at 1.0. The cultures were then shifted to 16°C and protein expression was induced by culturing with 0.1 mM isopropyl β-D-thiogalactopyranoside (IPTG) overnight. Cells were collected and suspended in Buffer I (50 mM Tris-HCl (pH 8.0), 150 mM NaCl) with 1 mg/mL lysozyme, then sonicated on ice. Cell lysates were spun down to remove cellular debris (4,000 × g, 20 min), followed by pelleting the membrane fractions (20,000 × g, 1.5 h). Membrane factions were then suspended in Buffer I with 1% Triton X-100, followed by centrifugation (12,000 × g, 20 min) to remove insoluble material. The Alg1 mutant proteins were purified from the resulting supernatant by Ni-NTA affinity chromatography (GE healthcare, Buckinghamshire, UK). The purified proteins were dialyzed in dialysate buffer (25 mM TrisHCl (pH 8.0), 50 mM NaCl) overnight at 4°C, further concentrated to 1 mg/mL by centrifugation with amicon 10KDa NMWL membrane (Millipore, MA, USA).
Activity assay in vitro
An MS-based quantitative assay was used for measuring the enzymatic activity of Alg1 (Li et al. 2017 (Li et al. , 2018 . Briefly, the reaction MATα ade2-1 ura3-1 his3-11 trp1-1 leu2-3,112 can1-100 XGY29 As in W303a and GAL1/10 pr -ALG1::kanMX4 XGY31
As in XGY29 and inserted with pXX1 XGY32
As in XGY29 and inserted with pXX2 XGY33
As in XGY29 and inserted with pXX3 XGY34
As in XGY29 and inserted with pXX5 XGY35
As in XGY29 and inserted with pXX6 XGY36
As in XGY29 and inserted with pXX7 XGY37
As in XGY29 and inserted with pXX8 XGY38
As in XGY29 and inserted with pXX9 XGY39
As in XGY29 and inserted with pXX12 contained the following solution in a final volume of 0.05 mL:20 mM Tris-HCl (pH 7.2), 1 mM DTT, 0.15 mM EDTA, 0.13% NP-40, 50 μM GlcNAc2-PP-Phy (phytanyl-pyrophosphoryl-α-N, N'-diacetylchitobioside), 2 mM GDP-Man, 10 mM MgCl 2 and 4 ng mutant Alg1 protein. The enzymatic reaction was carried out at 30°C for 30 min and terminated at 100°C for 2 min. The reaction mixture was lyophilized, then redissolved in 0.2 mL of 20 mM HCl [H 2 O/MeOH (4:1)] and incubated at 100°C for 1 h to release glycans from the pyrophosphate phytanyl (PP-Phy). The water-soluble fraction was desalted by solid-phase extraction using 1 mL Supelclean ENVI-Carb slurry (Sigma, MO) equilibrated with 2% acetonitrile. The column was washed by 2% acetonitrile (10 mL), and oligosaccharide was eluted with 25% acetonitrile (3.0 mL) and lyophilized. Desalted oligosaccharides were injected into a Dionex Ultimate 3000 UPLC (Thermo Scientific, MA, conditions: column, Waters Acquity UPLC BEH Amide Column 1.7 μm 2.1 × 100 mm; eluent A, CH 3 CN; eluent B, H 2 O; gradient: 0-2 min, 20% B; 2-15 min, 20-50% B; 15-18 min, 50% B; flow rate, 0.2 mL/min). The ESI-MS of eluate was measured on a TSQ Quantum Ultra (Thermo Scientific, MA) in the mass range of 400-800 m/z (positive mode). Oligosaccharide transfer rate was quantified by calculating the peak intensity in LC-ESI-MS using Xcalibur (Version 2.0, Thermo Scientific, USA)
